MDS: navigating the complex course.
Fortenbaugh
Cathy
C
Pennsylvania Oncology Hematology Associates, Philadelphia, USA.
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077269:Lenalidomide; D008487:Medical History Taking; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D009367:Neoplasm Staging; D024802:Nurse's Role; D009730:Nursing Assessment; D009859:Oncology Nursing / Q000458:organization & administration*; D010808:Physical Examination; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D013792:Thalidomide; D000077269:Lenalidomide; D001374:Azacitidine